Employers have long competed on salary, flexibility, and perks. Now, a new benefit is entering the equation — one that is far more personal, expensive, and increasingly influential in hiring decisions: access to GLP-1 medications.
Drugs like Ozempic and Zepbound have surged in demand for their effectiveness in weight loss and metabolic health.
In modern work society, GLP-1 weight loss drugs (used by 12% of Americans), skincare, and fitness regimes have become part of a larger trend where health, energy, and visual vitality are considered professional assets. It makes sense that employers are considering finding ways to offer more of these wellness benefits.
But as demand rises for wellness products and weight loss drugs, so do costs and access barriers.
Most GLP-1 medications cost around $1,000 per month without insurance.
In response, a growing number of companies are offering GLP-1s directly to employees, some through traditional insurance plans, as well as through alternative models designed to lower costs and expand access.
Benefits Are Becoming a Hiring Advantage
Healthcare coverage choices have always influenced job decisions, but the demand for GLP-1s is making that dynamic more visible and more urgent.
“Prospective employees have been choosing between employers based on healthcare benefits for decades — the demand for GLP-1s is just making it more apparent,” Jay Bregman, CEO and founder of Andel (an app providing GLP-1s and other medications as employee benefits) told Allwork.Space.
The underlying issue, he explains, is access. Even insured workers struggle to obtain medications due to prior authorizations and coverage limitations.
According to Bregman, “one in three insured Americans say prior authorizations are a major barrier to reliable healthcare coverage,” creating frustration that spills into how employees view their employers.
That frustration has measurable consequences.
“Eighty percent of employees have a worse perception of their employer after losing GLP-1 coverage,” he said, adding that it can also make workers feel undervalued.
For employers, the implications are clear: making healthcare easier to access is becoming a competitive advantage.
“Companies that make healthcare easier for their employees have an edge in attracting and retaining new hires,” Bregman said.
At the same time, companies are facing rising costs. Drug spending is increasing roughly 20% year over year, with GLP-1 medications contributing significantly to that growth. Many employers are responding by cutting coverage entirely.
Bregman says the solution is for employers, employees and Pharma to be put together in a cooperative technology marketplace. He believes that GLP-1s as a workplace benefit is solving the same problem as a gym or wellness benefit, just with far greater magnitude, efficacy, and health benefits that all employees and the employer can enjoy in the form of lower costs and greater happiness and productivity.
When Health Benefits Start Driving Performance
The rise of GLP-1s as a workplace benefit raises a more complex question: are companies solving a health issue, or tying employee performance more closely to medication access?
Bregman frames it as an extension of existing wellness programs, but with stronger results.
There is also evidence that losing access has immediate workplace effects.
“When GLP-1 coverage is dropped by employers, we see immediate impacts: employees lose motivation, productivity, and satisfaction, with over 30% reporting decreased motivation,” he noted.
In that sense, access to medication is becoming intertwined with day-to-day work outcomes.
A New Layer of the Talent Equation
As companies rethink benefits in a tighter labor market, healthcare access is becoming even more directly tied to hiring and retention strategies. The ability to offer reliable, affordable treatment is emerging as a differentiator — particularly when traditional systems fall short.
For employees, this changes expectations around what a job provides. For employers, it adds a new layer of responsibility…and opportunity.
In a labor market where perks have grown increasingly personal, access to GLP-1s may be one of the clearest signals yet that competition for talent is extending beyond salary and into the benefits employees value most.
